Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / AP3B2

AP3B2

Basics

Aliases:
This biomarker is also known as:
  • Neuronal adaptin-like protein, beta-subunit,
  • neuron-specific vesicle coat protein beta-NAP,
  • Neuron-specific vesicle coat protein beta-NAP,
  • adaptor protein complex AP-3 subunit beta-2,
  • adapter-related protein complex 3 subunit beta-2,
  • adaptor-related protein complex 3, beta 2 subunit,
  • Clathrin assembly protein complex 3 beta-2 large chain,
  • beta-3B-adaptin,
  • Adaptor protein complex AP-3 subunit beta-2,
  • NAPTB,
  • Adapter-related protein complex 3 subunit beta-2,
  • clathrin assembly protein complex 3 beta-2 large chain,
  • Beta-3B-adaptin,
  • AP-3 complex subunit beta-2,

View in BioMuta

Description…

AP3B2 is the beta 2 subunit of adaptor-related protein complex 3, a neuron-specific complex that is thought to serve neuron-specific functions such as neurotransmitter release.

Attributes

QA State: Curated
Type: Protein
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Breast

Attributes

Phase: Two
QA State: Under Review

Overview

No additional breast data available.

Performance Comment

AP3B2 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html